Australia develops AI model to help epilepsy patients become seizure-free

A study led by Monash University in Australia and believed to be a world first has demonstrated that an Artificial Intel...

September 1, 2022 | Thursday | News
Australia to focus research on five virus families likely to cause future pandemics

The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia's national science agency,...

August 30, 2022 | Tuesday | News
Pfizer emerges as leading company in Asia for COVID-19 response

Pfizer has been ranked first in its COVID-19 response, patient centricity, patient safety and bringing innovative, high-...

August 27, 2022 | Saturday | News
Some cancer immunotherapy treatments may damage fertility: Australian study

Researchers from Monash University, Australia have discovered that some immunotherapy treatments used to treat cancer ca...

August 29, 2022 | Monday | News
Australia cracks down on counterfeit drugs

The Therapeutic Goods Administration (TGA) led Australia's participation in INTERPOL's Operation Pangea, which tackles t...

August 26, 2022 | Friday | News
Australia opens first dedicated children’s immunotherapy centre

Australia’s first dedicated children’s immunotherapy centre will investigate treatments to not only increase...

August 25, 2022 | Thursday | News
Alterity Therapeutics opens first site in Europe for drug trial of Multiple System Atrophy

Australia-based Alterity Therapeutics has announced that the company’s Phase 2 clinical trial of ATH434 for ...

August 25, 2022 | Thursday | News
Australia launches mobile service for mental healthcare

The Australian Government has announced the launch of the new Head to Health phone service which will help Aus...

August 23, 2022 | Tuesday | News
Hydrix receives approval for Guardian device in Singapore

Australia's Hydrix Limited has announced that the Health Services Authority of Singapore (HSA) has approved The Guardian...

August 23, 2022 | Tuesday | News
Long COVID-19 study in Australia identifies potential diagnostic and therapeutic targets

Australia-based Antisense Therapeutics has announced the outcomes from its collaboration to study the neurological aspec...

August 23, 2022 | Tuesday | News
Australia launches world-first preventative DNA screening for cancer, heart disease risk

The nationally collaborative project, led by Monash University and supported by researchers and clinicians across Austra...

August 22, 2022 | Monday | News
Australia invests $30 M to support vital brain and mental health research

Monash University has received a $30 million philanthropic gift that will fund vital mental health research and preventa...

August 19, 2022 | Friday | News
Australian startup Carina Biotech raises $7.5 M

Australia-based startup Carina Biotech has raised $7.5 million at first close of its current funding round, welcoming on...

August 18, 2022 | Thursday | News
EpiAxis Therapeutic, Peptilogics enter strategic drug discovery partnership

Australia's EpiAxis Therapeutics, a leading epigenetics company with a focus on the treatment, diagnosis and monitoring ...

August 17, 2022 | Wednesday | News
Moderna to build first mRNA production facility in Southern Hemisphere

Australia's Monash University has announced that US-based firm Moderna will be joining other world-leading research and ...

August 16, 2022 | Tuesday | News
Australia investigates how to stop painful chemo for kids

Stopping children undergoing chemotherapy from feeling pain and other debilitating side-effects is the focus of research...

August 12, 2022 | Friday | News
CSIRO opens 'missing link' lab to developing Australian vaccine pipeline

Commonwealth Scientific and Industrial Research Organisation (CSIRO), an Australian Government agency responsible for sc...

August 11, 2022 | Thursday | News
Starpharma signs new research agreement with Merck

Australian biotechnology company Starpharma has signed a new DEP Research Agreement with MSD, the trade name of Mer...

August 10, 2022 | Wednesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls